{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:43:05Z","timestamp":1762504985857,"version":"build-2065373602"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T00:00:00Z","timestamp":1106870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To study the influence of oxybutynin, tolterodine or trospium chloride, anticholinergics used to treat bladder overactivity, on sleep and the cognitive skills of healthy volunteers aged \u2265\u200a50\u2003years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUBJECTS AND METHODS<\/jats:title>\n                    <jats:p>In a randomized, double\u2010blind, placebo\u2010controlled study with a crossover design, 24 healthy sleepers (12 men and 12 women) aged 51\u201365\u2003years underwent polysomnographic recordings and cognitive tests in a sleep laboratory. Study medications were given as a single dose containing the total recommended daily dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>There was a significant reduction in rapid\u2010eye movement (REM) sleep of \u2248\u200a15% and a slightly (but not significantly) greater REM latency after oxybutynin and tolterodine than with placebo. After trospium chloride, REM duration and latency were comparable with placebo. There was no effect of the tested anticholinergics on cognitive and subjective sleep variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Individuals aged \u2265\u200a50\u2003years had a more distinct impairment of REM sleep after oxybutynin and tolterodine than had young people, but the reduction in REM sleep did not reach a pathological degree in this single\u2010dose study. There was no apparent impairment of concentration or cognitive function, but impairment of cognitive function and neuropsychological side\u2010effects cannot be excluded, especially when elderly patients with impaired REM sleep from various psychiatric diseases (e.g. depression) and\/or sleep disturbances are given oxybutynin or tolterodine in long\u2010term treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2005.05296.x","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T05:00:31Z","timestamp":1106974831000},"page":"346-349","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged \u2265\u200a50\u2003years"],"prefix":"10.1111","volume":"95","author":[{"given":"Konstanze","family":"Diefenbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Arold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Wollny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Schwantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Haselmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivar","family":"Roots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,28]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"209","article-title":"Importance of pharmacological and physiochemical properties for tolerance of antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia \u2013 chances for improvement of therapy","volume":"37","author":"Schwantes U","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP38223"},{"key":"e_1_2_8_4_2","first-page":"43","volume-title":"Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics","author":"Nies AS","year":"1996"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1998.tb01006.x"},{"key":"e_1_2_8_6_2","first-page":"217","article-title":"Alltags\u2010 und Verkehrssicherheit unter Inkontinenz\u2010Medikation. Neue Untersuchungen zum Sicherheitspotential urologischer Anticholinergika","volume":"50","author":"Herberg KW.","year":"1999","journal-title":"Die Med Welt"},{"volume-title":"British National Formulary No. 34.","year":"1997","key":"e_1_2_8_7_2"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00191165"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7119.1363"},{"key":"e_1_2_8_10_2","first-page":"590","article-title":"Neuropsychiatric adverse effects attributed to use of oxybutynin","volume":"142","author":"T\u2019Veld BA","year":"1998","journal-title":"Ned Tijschr Geneeskd"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17257"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00599-2"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.4.267.30943"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200312043492325"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.5.771"},{"key":"e_1_2_8_16_2","first-page":"3","volume-title":"Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics","author":"Benet LZ","year":"1996"},{"key":"e_1_2_8_17_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1201\/9780367800529","volume-title":"The Blood\u2013Brain Barrier and Drug Delivery to the CNS","author":"Bradbury MW.","year":"2000"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200323060-00003"},{"key":"e_1_2_8_19_2","unstructured":"RechtschaffenA KalesA.A manual of standardized terminology techniques and scoring system for sleep stages of human sleep subjects. Washington (DC):US Government Printing Office US Public Health Service 1968"},{"key":"e_1_2_8_20_2","first-page":":","volume-title":"Testkatalog 2000\/01","author":"Oswald WD","year":"2000"},{"key":"e_1_2_8_21_2","first-page":":","volume-title":"Testkatalog 2000\/01","author":"Brickenkamp R","year":"2000"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975186727"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/274490a0"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(89)90193-5"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00431-3"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122010528"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02191586"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2005.05296.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2005.05296.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:04:31Z","timestamp":1761757471000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2005.05296.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1464-410X.2005.05296.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2005.05296.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2005,1,28]]},"assertion":[{"value":"2005-01-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}